Atea Pharmaceuticals (AVIR) Ownership - Who Owns Atea Pharmaceuticals?

244 Followers

Atea Pharmaceuticals (AVIR) Ownership Overview

11.07% Insiders

16.64% Mutual Funds

22.48% Other Institutional Investors

10.80% ETFs

39.01% Public Companies and

Individual Investors

The ownership structure of Atea Pharmaceuticals (AVIR) stock is a mix of institutional, retail, and individual investors. Approximately 49.92% of the company’s stock is owned by Institutional Investors, 11.07% is owned by Insiders, and 39.01% is owned by Public Companies and Individual Investors.

The ownership structure of Atea Pharmaceuticals (AVIR) stock is a mix of institutional, retail, and individual investors. Approximately 39.12% of the company’s stock is owned by Institutional Investors, 11.07% is owned by Insiders, and 10.80% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
May 20, 2026	Polly A. Murphy	xxxxxxxxxxxxx	$25437

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value

Show More Hedge Fund Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
6,633,855	Insider	8.29%	28,923,608
4,388,875	Institution	5.48%	19,135,495
3,758,984	Institution	4.70%	16,389,170
3,206,921	Institution	4.01%	13,982,176
3,177,776	Institution	3.97%	13,855,103
823,576	Insider	1.03%	3,590,791
776,497	Institution	0.97%	3,385,527
763,875	Institution	0.95%	3,330,495
661,185	Institution	0.83%	2,882,767
660,281	Institution	0.83%	2,878,825

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
4,388,875	Institution	5.48%	19,135,495
3,177,776	Institution	3.97%	13,855,103
776,497	Institution	0.97%	3,385,527
763,875	Institution	0.95%	3,330,495
661,185	Institution	0.83%	2,882,767
660,281	Institution	0.83%	2,878,825
487,349	Institution	0.61%	2,124,842
410,029	Institution	0.51%	1,787,726
261,130	Institution	0.33%	1,138,527
237,534	Institution	0.30%	1,035,648

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	2,369,422	Institution	2.96%	11,065,201
iShares Russell 2000 ETF	1,634,435	Institution	2.04%	7,126,137
Vanguard Extended Market ETF	816,986	Institution	1.02%	3,815,325
iShares Russell 2000 Value ETF	615,518	Institution	0.77%	2,683,658
iShares Biotechnology ETF	446,672	Institution	0.56%	1,947,490
Vanguard Russell 2000 ETF	358,829	Institution	0.45%	1,675,731
Schwab U.S. Small-Cap ETF	345,943	Institution	0.43%	1,497,933
Dimensional U.S. Small Cap ETF	263,930	Institution	0.33%	1,142,817
U.S. Micro Cap Portfolio ETF	225,519	Institution	0.28%	1,213,292
iShares Core S&P Total U.S. Stock Market ETF	190,371	Institution	0.24%	830,018

FAQ

Who Owns Atea Pharmaceuticals, Inc. (AVIR)?

According to the latest TipRanks data, approximately 22.48% of the company's stock is held by institutional investors, 11.07% is held by insiders, and 39.01% is held by retail investors.

What percentage of Atea Pharmaceuticals, Inc. (AVIR) stock is held by institutional investors?

According to the latest TipRanks data, approximately 22.48% of Atea Pharmaceuticals, Inc. (AVIR) stock is held by institutional investors.

What percentage of Atea Pharmaceuticals, Inc. (AVIR) stock is held by retail investors?

According to the latest TipRanks data, approximately 39.01% of Atea Pharmaceuticals, Inc. (AVIR) stock is held by retail investors.

Who owns the most shares of Atea Pharmaceuticals, Inc. (AVIR)?

Jean-Pierre Sommadossi owns the most shares of Atea Pharmaceuticals, Inc. (AVIR).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.